查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417405

心臟衰竭POC/LOC 设备的全球市场：趋势、预测与竞争分析（~2030 年）

Heart Failure POC & LOC Device Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到2030年，全球心臟衰竭POC/LOC设备市场规模将达到约3亿美元，2024年至2030年复合年增长率为15.9%。心臟衰竭POC/LOC 设备市场的未来看起来充满希望，诊所、医院、家庭、辅助生活设施和实验室市场都有机会。该市场的主要驱动因素是小型化、实验室晶片技术，该技术在提高疾病诊断方面的成本效率、通量、易操作性、分析和心血管疾病诊断方面显示出巨大潜力。致力于创建基于实验室晶片技术的创新检测方法。

心臟衰竭POC/LOC 设备市场洞察

Lucintel 预测，由于人们对心血管疾病死亡率和发病率的担忧不断增加，微流体在预测期内仍将是最大的细分市场。

这是因为门诊诊所越来越多地大规模采用照护现场设备，以实现及时、准确的诊断，并为心臟衰竭做出明智的治疗决策。

在预测期内，北美可能仍然是最大的地区，因为美国市场的主要企业对全球心臟衰竭领域的显着有机收益成长做出了重大贡献。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球心臟衰竭POC/LOC 设备市场预计将达到 3 亿美元。

Q2.市场成长预测如何？

A2. 预计 2024 年至 2030 年，全球心臟衰竭POC/LOC 设备市场将以 15.9% 的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是小型化，实验室晶片技术在成本效率、通量、操作简便性和分析方面显示出增强疾病诊断的巨大潜力，从而改善心血管疾病的诊断。目前正在开发基于实验室晶片技术的创新检测方法。

Q4.市场的主要细分市场是什么？

A4.心臟衰竭POC/LOC 设备市场的未来看起来充满希望，诊所、医院、家庭、辅助生活医疗机构和实验室市场都有机会。

Q5.市场上主要企业有哪些？

A5. 生产心臟衰竭POC/LOC 设备的一些主要企业如下。

  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Quidel
  • bioMerieux
  • Trinity BiotechInstrumentation

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于人们对心血管疾病死亡率和发病率的担忧日益增加，微流体在预测期内仍将是最大的细分市场。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 预计北美在预测期内仍将是最大的地区，因为美国市场的主要企业对全球心臟衰竭领域的显着有机收益成长做出了重大贡献。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球心臟衰竭POC/LOC 设备市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球心臟衰竭POC/LOC设备市场趋势（2018-2023）与预测（2024-2030）
  • 全球心臟衰竭POC/LOC 设备市场：依技术分类
    • 微流体
    • 基于阵列的系统
    • 其他的
  • 全球心臟衰竭POC/LOC 设备市场：依测试类型
    • 蛋白质体学测试
    • 代谢组测试
    • 基因组测试
  • 全球心臟衰竭POC/LOC 设备市场：依最终用途产业划分
    • 诊所
    • 医院
    • 家
    • 生活支援医疗设施
    • 研究员
    • 其他的

第四章市场趋势与预测分析：按地区（2018-2030）

  • 按地区分類的全球心臟衰竭POC/LOC 设备市场
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 依技术
    • 按测试类型
    • 按最终用途行业
    • 按地区
  • 全球心臟衰竭POC/LOC器材市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球心臟衰竭POC/LOC设备市场产能
    • 全球心臟衰竭POC/LOC设备市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Quidel
  • bioMerieux
  • Trinity BiotechInstrumentation
简介目录

Heart Failure POC & LOC Device Trends and Forecast

The future of the heart failure POC & LOC device market looks promising with opportunities in the clinics, hospitals, homes, assisted living healthcare facilities, and laboratories markets. The heart failure POC & LOC device market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 15.9% from 2024 to 2030. The major drivers for this market are miniaturization, lab-on-chip technology shows significant potential for enhancing disease diagnosis in terms of cost-efficiency, throughput, simplicity of operation, and analysis and research and development efforts directed at creating innovative assays based on lab-on-chip technology for cardiovascular disease diagnosis.

A more than 150-page report is developed to help in your business decisions.

Heart Failure POC & LOC Device by Segment

The study includes a forecast for the global heart failure POC & LOC device by technology, test type, end use industry, and region.

Heart Failure POC & LOC Device Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Microfluidics
  • Array-Based Systems
  • Others

Heart Failure POC & LOC Device Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Proteomic Testing
  • Metabolomic Testing
  • Genomic Testing

Heart Failure POC & LOC Device Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Clinics
  • Hospitals
  • Home
  • Assisted Living Healthcare Facilities
  • Laborator
  • Others

Heart Failure POC & LOC Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Heart Failure POC & LOC Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart failure POC & LOC device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart failure POC & LOC device companies profiled in this report include-

  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Quidel
  • bioMerieux
  • Trinity BiotechInstrumentation

Heart Failure POC & LOC Device Market Insights

Lucintel forecasts that microfluidics will remain the largest segment over the forecast period due to increasing worry regarding mortality and morbidity rates stemming from cardiovascular diseases.

Within this market, clinic will remain the largest segment due to outpatient clinics are increasingly employing point-of-care devices on a larger scale to achieve timely and accurate diagnoses, enabling well-informed treatment decisions for heart failure.

North America will remain the largest region over the forecast period due to major key players in the u.s. market are significantly contributing to substantial organic revenue growth in the global heart failure sector.

Features of the Heart Failure POC & LOC Device Market

Market Size Estimates: Heart failure POC & LOC device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Heart failure POC & LOC device market size by technology, test type, end use industry, and region in terms of value ($B).

Regional Analysis: Heart failure POC & LOC device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, test type, end use industry, and regions for the heart failure POC & LOC device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart failure POC & LOC device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the heart failure POC & LOC device market size?

Answer: The global heart failure POC & LOC device market is expected to reach an estimated $0.3 billion by 2030.

Q2. What is the growth forecast for heart failure POC & LOC device market?

Answer: The global heart failure POC & LOC device market is expected to grow with a CAGR of 15.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the heart failure POC & LOC device market?

Answer: The major drivers for this market are miniaturization, lab-on-chip technology shows significant potential for enhancing disease diagnosis in terms of cost-efficiency, throughput, simplicity of operation, and analysis and research and development efforts directed at creating innovative assays based on lab-on-chip technology for cardiovascular disease diagnosis.

Q4. What are the major segments for heart failure POC & LOC device market?

Answer: The future of the heart failure POC & LOC device market looks promising with opportunities in the clinics, hospitals, homes, assisted living healthcare facilities, and laboratories markets.

Q5. Who are the key heart failure POC & LOC device market companies?

Answer: Some of the key heart failure POC & LOC device companies are as follows.

  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Quidel
  • bioMerieux
  • Trinity BiotechInstrumentation

Q6. Which heart failure POC & LOC device market segment will be the largest in future?

Answer: Lucintel forecasts that microfluidics will remain the largest segment over the forecast period due to increasing worry regarding mortality and morbidity rates stemming from cardiovascular diseases.

Q7. In heart failure POC & LOC device market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to major key players in the u.s. market are significantly contributing to substantial organic revenue growth in the global heart failure sector.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the heart failure POC & LOC device market by technology (microfluidics, array-based systems, and others), test type (proteomic testing, metabolomic testing, and genomic testing), end use industry (clinics, hospitals, home, assisted living healthcare facilities, laborator, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Heart Failure POC & LOC Device Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Heart Failure POC & LOC Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Heart Failure POC & LOC Device Market by Technology
    • 3.3.1: Microfluidics
    • 3.3.2: Array-Based Systems
    • 3.3.3: Others
  • 3.4: Global Heart Failure POC & LOC Device Market by Test Type
    • 3.4.1: Proteomic Testing
    • 3.4.2: Metabolomic Testing
    • 3.4.3: Genomic Testing
  • 3.5: Global Heart Failure POC & LOC Device Market by End Use Industry
    • 3.5.1: Clinics
    • 3.5.2: Hospitals
    • 3.5.3: Home
    • 3.5.4: Assisted Living Healthcare Facilities
    • 3.5.5: Laborator
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Heart Failure POC & LOC Device Market by Region
  • 4.2: North American Heart Failure POC & LOC Device Market
    • 4.2.2: North American Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
  • 4.3: European Heart Failure POC & LOC Device Market
    • 4.3.1: European Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
    • 4.3.2: European Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
  • 4.4: APAC Heart Failure POC & LOC Device Market
    • 4.4.1: APAC Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
    • 4.4.2: APAC Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
  • 4.5: ROW Heart Failure POC & LOC Device Market
    • 4.5.1: ROW Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
    • 4.5.2: ROW Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Technology
    • 6.1.2: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Test Type
    • 6.1.3: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Region
  • 6.2: Emerging Trends in the Global Heart Failure POC & LOC Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Heart Failure POC & LOC Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Heart Failure POC & LOC Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Danahar
  • 7.3: Siemens Healthineers
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Quidel
  • 7.6: bioMerieux
  • 7.7: Trinity BiotechInstrumentation